Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guobang PharmaSHSE:605507 -3.33%86 Days Inventory is 134.37 as of Jun. 2026, which is 12% above its 10-year median of 119.70. GuruFocus rates SHSE:605507 with a GF Score™ of 86/100 and a GF Value™ of ¥15.69 (Fairly Valued). The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Guobang Pharma ranks better than 62.91% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Guobang Pharma's Average Total Inventories for the
three
months ended in Jun. 2026 was ¥1,804 Mil. Guobang Pharma's Cost of Goods Sold for the
three
months ended in Jun. 2026 was ¥1,225 Mil.
Hence, Guobang Pharma's Days Inventory for the
three
months ended in Jun. 2026 was 134.37.
The historical rank and industry rank for Guobang Pharma's Days Inventory or its related term are showing as below:
SHSE:605507'
s Days Inventory Range Over the Past 10 Years
Min: 108.98 Med: 119.7 Max: 133.94
Current: 133.94
During the past 9 years, Guobang Pharma's highest Days Inventory was 133.94. The lowest was 108.98. And the median was 119.70.
SHSE:605507's Days Inventory is ranked better than 62.91% of 922
companies
in the Drug Manufacturers industry
Industry Median: 165.005
vs SHSE:605507: 133.94
Guobang Pharma's Days Inventory
increased
from Jun. 2025 (115.57) to Jun. 2026 (134.37).
It might indicate that Guobang Pharma's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Guobang Pharma's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.68.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Guobang Pharma's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 1.11.
Guobang Pharma (SHSE:605507) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Guobang Pharma's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Guobang Pharma's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Guobang Pharma Days Inventory Related Terms
Guobang Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Guobang Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Guobang Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guobang Pharma Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Guobang Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Guobang Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guobang Pharma (SHSE:605507) has a Days Inventory of 134.37 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Guobang Pharma and its competitors. This is 12% above median its historical median of 119.70. Over the past decade, Guobang Pharma's Days Inventory has ranged from 108.98 to 133.94. According to the industry distribution chart, Guobang Pharma ranks #342 out of 922 companies in the Drug Manufacturers industry, placing it in the top 37.1%.
Is Guobang Pharma's Days Inventory too high?
Guobang Pharma's current Days Inventory of 134.37 is 12% above median its 10-year median of 119.70. Over the past 10 years, this metric has ranged from a low of 108.98 to a high of 133.94. The Drug Manufacturers industry median Days Inventory is 165.01. Guobang Pharma's value of 134.37 is 18.6% below this industry median. Based on the distribution chart, Guobang Pharma ranks #342 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Guobang Pharma has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guobang Pharma's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Guobang Pharma ranks #342 out of 922 companies for Days Inventory. This puts Guobang Pharma in the upper half of its industry. The industry median Days Inventory is 165.01. Guobang Pharma's value of 134.37 is 18.6% below this benchmark. Historically, Guobang Pharma's own Days Inventory has ranged from 108.98 to 133.94 over the past decade. While the company's 10-year median is 119.70 vs. the industry median of 165.01, Guobang Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.01, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guobang Pharma's current Days Inventory of 134.37 is 18.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Guobang Pharma and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guobang Pharma's current Days Inventory is 134.37, which is 12% above median its own 10-year median of 119.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guobang Pharma stock overvalued right now?
Based on GuruFocus' analysis, Guobang Pharma (SHSE:605507) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.69, compared to a current price of ¥15.37 — trading 2% below its estimated fair value. The current Days Inventory is 134.37, which is 12% above median its 10-year median of 119.70 and 18.6% below the Drug Manufacturers industry median of 165.01. Guobang Pharma's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Guobang Pharma (SHSE:605507), the current Days Inventory is 134.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guobang Pharma (SHSE:605507) Overvalued in 2026?
Based on GuruFocus' analysis, Guobang Pharma stock appears to be undervalued.
The current stock price of ¥15.37 is trading 2% below its estimated GF Value™ of ¥15.69.
GuruFocus considers Guobang Pharma to be Fairly Valued.
Key valuation signals for SHSE:605507:
Days Inventory: 134.37 (12% above median its 10-year median of 119.70)
GF Value™: ¥15.69 vs. price of ¥15.37 (2% below fair value)
Industry Position: 18.6% below the Drug Manufacturers median (#342 of 922)
No single metric tells the full story. See the SHSE:605507 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.
86GF Score
Get the complete analysis for SHSE:605507
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605507 has been successfully added to your 
